tanshinone has been researched along with GRL-0617 in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (GRL-0617) | Trials (GRL-0617) | Recent Studies (post-2010) (GRL-0617) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 13 | 0 | 12 |
| Protein | Taxonomy | tanshinone (IC50) | GRL-0617 (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 0.6 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.6 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.6 | |
| Procathepsin L | Homo sapiens (human) | 0.6 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.6 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.6 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 1.1567 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.1191 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.6 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
1 review(s) available for tanshinone and GRL-0617
| Article | Year |
|---|---|
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |